152 related articles for article (PubMed ID: 2186610)
1. Protection of the myocardium during myocardial infarction: pharmacologic protection during thrombolytic therapy.
Willerson JT; Buja LM
Am J Cardiol; 1990 May; 65(19):35I-41I. PubMed ID: 2186610
[TBL] [Abstract][Full Text] [Related]
2. Infarct size reduction: a review of the clinical trials.
Campbell CA; Przyklenk K; Kloner RA
J Clin Pharmacol; 1986; 26(5):317-29. PubMed ID: 2871053
[TBL] [Abstract][Full Text] [Related]
3. The reduction of infarct size--forty years of research.
Ferreira R
Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
[TBL] [Abstract][Full Text] [Related]
4. Current perspectives on reperfusion therapy for acute ST-segment elevation myocardial infarction: integrating pharmacologic and mechanical reperfusion strategies.
Waters RE; Mahaffey KW; Granger CB; Roe MT
Am Heart J; 2003 Dec; 146(6):958-68. PubMed ID: 14660986
[TBL] [Abstract][Full Text] [Related]
5. [Strategies to improve reperfusion with fibrinolytic therapy in ST-T elevation myocardial infarction].
Jerjes-Sánchez C; Sosa del Angel E; García Sosa A; Reyes Cerezo E; Garza Ruiz A
Arch Cardiol Mex; 2003; 73(1):46-58. PubMed ID: 12820494
[TBL] [Abstract][Full Text] [Related]
6. Acute myocardial infarction: enhancing the results of reperfusion therapy.
Reeder GS
Mayo Clin Proc; 1995 Dec; 70(12):1185-90. PubMed ID: 7490920
[TBL] [Abstract][Full Text] [Related]
7. Reperfusion in acute myocardial infarction.
Lavie CJ; Gersh BJ; Chesebro JH
Mayo Clin Proc; 1990 Apr; 65(4):549-64. PubMed ID: 2332994
[TBL] [Abstract][Full Text] [Related]
8. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
[TBL] [Abstract][Full Text] [Related]
9. Adjunctive therapy after reperfusion therapy in acute myocardial infarction.
Dries DL; Solomon AJ; Gersh BJ
Clin Cardiol; 1998 Jun; 21(6):379-86. PubMed ID: 9631265
[TBL] [Abstract][Full Text] [Related]
10. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
Przyklenk K; Kloner RA
Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Platelet GPVI Protects Against Myocardial Ischemia-Reperfusion Injury.
Pachel C; Mathes D; Arias-Loza AP; Heitzmann W; Nordbeck P; Deppermann C; Lorenz V; Hofmann U; Nieswandt B; Frantz S
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):629-35. PubMed ID: 26916731
[TBL] [Abstract][Full Text] [Related]
12. Adenosine for myocardial protection in acute myocardial infarction.
Granger CB
Am J Cardiol; 1997 Jun; 79(12A):44-8. PubMed ID: 9223363
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agent.
Quintana M; Kahan T; Hjemdahl P
Am J Cardiovasc Drugs; 2004; 4(3):159-67. PubMed ID: 15134468
[TBL] [Abstract][Full Text] [Related]
14. Reperfusion injury and its pharmacologic modification.
Opie LH
Circulation; 1989 Oct; 80(4):1049-62. PubMed ID: 2571429
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic reperfusion strategies for the treatment of ST-segment elevation myocardial infarction.
Young JJ; Kereiakes DJ
Rev Cardiovasc Med; 2003; 4(4):216-27. PubMed ID: 14668689
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological reperfusion in acute myocardial infarct].
Lorenzoni R; Gensini GF; De Caterina R
G Ital Cardiol; 1998 Dec; 28(12):1441-55. PubMed ID: 9887401
[No Abstract] [Full Text] [Related]
17. Reperfusion strategies in ST-segment elevation myocardial infarction.
Stiermaier T; Desch S; Schuler G; Thiele H; Eitel I
Minerva Med; 2013 Aug; 104(4):391-411. PubMed ID: 24008602
[TBL] [Abstract][Full Text] [Related]
18. The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trends.
Campbell KR; Ohman EM; Cantor W; Lincoff AM
Am J Cardiol; 2000 Apr; 85(8A):32C-8C. PubMed ID: 10793178
[TBL] [Abstract][Full Text] [Related]
19. Myocardial cellular alterations during myocardial ischemia and evolving infarction.
Willerson JT; Buja LM
Postgrad Med; 1988 Feb; Spec No():69-75. PubMed ID: 2894662
[TBL] [Abstract][Full Text] [Related]
20. Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model.
Wang K; Zhou X; Huang Y; Khalil M; Wiktor D; van Giezen JJ; Penn MS
Thromb Haemost; 2010 Sep; 104(3):609-17. PubMed ID: 20694285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
